Fetal Funding Favorable?🔬
No more funding fetal tissue research
The Trump administration halted funding for fetal tissue research on Wednesday. This is a win for anti-abortion lobbyists and a loss for medical researchers who used fetal tissue research in life-saving treatments, such as “vaccines for rubella and rabies and drugs to treat HIV.”
Good decision? Bad decision?
Much debate surrounds fetal tissue's place in medical research. The debate mostly centers on the fact the tissue can come from abortions, but also relates to the areas of research that fetal tissue contributes to, and whether adequate replacements exist.
Washington Examiner: Fetal tissue research, an abhorrent and needless use of taxpayer money, is done
The Federalist: Stop funding research using fetal tissue from abortions
Those who believe halting funding is good reference substitutes for some of fetal tissues purposes. One source goes so far as to say that in fact, fetal tissue research hasn’t contributed to anything scientific but only to the growing “market of aborted babies.”
Those who believe halting funding is bad cite the fact that fetal tissue remains critical to HIV research. They also claim that if the tissue’s not used it will just get thrown away, rendering it useless anyway.
Where's the common ground?
Both sets of sources agree that fetal tissue research has contributed, at least in some way, to vaccinations. Research shows that fetal research contributes to more than just a few vaccinations, and replacement may prove uncertain.
Share this story!